Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack

M Bhatia1, S C Howard, T G Clark

  • 1Stroke Prevention Research Unit, Radcliffe Infirmary, Centre for Statistics in Medicine, University of Oxford, UK.

Insights

Apolipoprotein B and its ratio to apolipoprotein A1 are strong predictors of ischaemic stroke risk in patients with a history of transient ischaemic attack (TIA). These findings suggest improved stroke risk assessment using lipid sub-fractions.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Lipidology

Background:

  • Traditional lipid markers (total cholesterol, LDL) show weak associations with ischaemic stroke compared to coronary heart disease.
  • Statins effectively prevent both stroke and CHD, suggesting other lipid sub-fractions influence stroke risk.
  • Apolipoprotein B is a stronger predictor of CHD than LDL cholesterol, but its role in stroke risk, especially post-TIA, is understudied.

Purpose of the Study:

  • To investigate the association between baseline lipid sub-fractions, including apolipoproteins, and ischaemic stroke risk in patients with a history of transient ischaemic attack (TIA).
  • To identify superior lipid biomarkers for predicting ischaemic stroke in this patient cohort.

Main Methods:

  • Prospective cohort study of 261 patients with previous TIA.
  • Assessment of baseline total cholesterol, LDL, HDL, apolipoprotein A1 (apo A1), and apolipoprotein B (apo B).
  • Cox proportional hazards models used to analyze associations with ischaemic stroke risk over 10-year follow-up.

Main Results:

  • The apolipoprotein B/apolipoprotein A1 ratio was the strongest independent predictor of ischaemic stroke (HR=2.94).
  • Apolipoprotein B alone was also a significant independent predictor (HR=2.26).
  • Total cholesterol, LDL, HDL, LDL/HDL ratio, and apo A1 did not show statistically significant associations with ischaemic stroke risk.

Conclusions:

  • Apolipoprotein B and the apo B/apo A1 ratio are significant predictors of ischaemic stroke in patients with prior TIA.
  • These apolipoprotein markers may offer improved prognostic value for ischaemic stroke risk assessment.
  • Further research is needed to confirm these findings in patients on statin therapy.
Abstract

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...